Check all documented drug-to-drug interactions. Major, moderate, and minor interactions with descriptions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Auranofin. Always confirm against the full prescribing information.
100 interactions
Amikacin
Auranofin may decrease the excretion rate of Amikacin which could result in a higher serum level.
Level 2 evidence
Abacavir
Auranofin may decrease the excretion rate of Abacavir which could result in a higher serum level.
Level 2 evidence
Abatacept
Auranofin may increase the hepatotoxic activities of Abatacept.
Level 2 evidence
Abemaciclib
Auranofin may increase the hepatotoxic activities of Abemaciclib.
Level 2 evidence
Abiraterone
Abiraterone may increase the hepatotoxic activities of Auranofin.
Level 2 evidence
Acamprosate
Acamprosate may increase the hepatotoxic activities of Auranofin.
Level 2 evidence
Acarbose
Acarbose may increase the hepatotoxic activities of Auranofin.
Level 2 evidence
Acebutolol
Auranofin may increase the hepatotoxic activities of Acebutolol.
Level 2 evidence
Aceclofenac
Aceclofenac may decrease the excretion rate of Auranofin which could result in a higher serum level.
Level 2 evidence
Acetaminophen
Acetaminophen may decrease the excretion rate of Auranofin which could result in a higher serum level.
Level 2 evidence
Acetazolamide
Acetazolamide may increase the excretion rate of Auranofin which could result in a lower serum level and potentially a reduction in efficacy.
Level 2 evidence
Acetylsalicylic acid
Acetylsalicylic acid may decrease the excretion rate of Auranofin which could result in a higher serum level.
Auranofin has 797 documented drug interactions. Always review the full list with a pharmacist before co-prescribing.
Auranofin has 1 major, 19 moderate, and 777 minor documented interactions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Auranofin. Always confirm against the full prescribing information.